BioMed Research International / 2017 / Article / Fig 3

Research Article

Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy

Figure 3

Overall Survival (a) and Progression-Disease Free Survival (b) (Kaplan-Meier method) according to standard (SDRT-TMZ) versus escalated (HDRT-TMZ) RT dose (log-rank test value < 0,05) in unmethylated patients with incomplete resection.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.